These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7856508)

  • 1. Caution with preparing suspensions.
    Horn JR
    Am Pharm; 1994 Dec; NS34(12):4-5. PubMed ID: 7856508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standard prescriptions for the formulation of medicinal preparations in pharmacies. I. Suspensions for dermal administration].
    Subert J; Kolár J; Vasková V
    Ceska Slov Farm; 2008 Apr; 57(2):55-7. PubMed ID: 18578413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crushing confusion.
    Menner A; Forrester C
    Aust Nurs J; 2005 Sep; 13(3):3. PubMed ID: 16502918
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation of a cimetidine oral suspension.
    Tortorici MP
    Am J Hosp Pharm; 1979 Jan; 36(1):22. PubMed ID: 758778
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with cimetidine oral suspension formulation.
    Sparkman HE
    Am J Hosp Pharm; 1979 May; 36(5):600. PubMed ID: 453211
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication advice.
    Solo L
    Aust Nurs J; 2005 Oct; 13(4):3. PubMed ID: 16496822
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines a good start.
    van Balen H; Elliott R
    Aust Nurs J; 2005 Sep; 13(3):3. PubMed ID: 16502919
    [No Abstract]   [Full Text] [Related]  

  • 8. Crushed medications: an emerging guideline.
    Simpson C
    Aust Nurs J; 2005 Jul; 13(1):21-3. PubMed ID: 16502943
    [No Abstract]   [Full Text] [Related]  

  • 9. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
    Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
    N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulk compounding in Canadian hospitals--a survey.
    Taddio A; Wilson W
    Can J Hosp Pharm; 1990 Oct; 43(5):213-8, xxxii. PubMed ID: 10107923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some theoretical aspects of bulk compounding technology. II. Suspensions.
    Am J Hosp Pharm; 1969 Sep; 26(9):548-50. PubMed ID: 5823458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Attempt at the preparation of an oral suspension of a complex tetracycline base and sodium hexametaphosphate].
    Delonca H; Joachim G; Agoes G; Diallo M
    Farmaco Prat; 1977 May; 32(5):203-13. PubMed ID: 862872
    [No Abstract]   [Full Text] [Related]  

  • 13. [PREPARATION OF INJECTABLE DRUG SUSPENSIONS. I. PREPARATION OF A 2.5 O AQUEOUS SUSPENSION OF DESOXYCORTICOSTERONE TRIMETHYLACETATE].
    VOLKOVINSKAIA LP; POZHARSKAIA AM
    Med Prom SSSR; 1963 Jul; 17():42-3. PubMed ID: 14069026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of manufacturing conditions and physical properties of sulfonamide and palmitate suspensions of chloramphenicol on their stability and resorption].
    Moës A
    Mem Acad R Med Belg; 1969; 5(6):797-899. PubMed ID: 5360537
    [No Abstract]   [Full Text] [Related]  

  • 15. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation, hydrolysis and resorption of chloramphenicol palmitate-suspensions].
    Braeckman P; van Severen R; Dony J; de Roeck A
    Pharmazie; 1966 Dec; 21(12):757-60. PubMed ID: 6001165
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug compounding position statement adopted.
    J Am Vet Med Assoc; 2001 Jan; 218(2):173. PubMed ID: 11195806
    [No Abstract]   [Full Text] [Related]  

  • 20. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.